Home/Pipeline/embrace® Active Scar Defense

embrace® Active Scar Defense

Prevention & reduction of hypertrophic and other raised scars from surgical incisions and traumatic lacerations

ApprovedActive

Key Facts

Indication
Prevention & reduction of hypertrophic and other raised scars from surgical incisions and traumatic lacerations
Phase
Approved
Status
Active
Company

About Neodyne Biosciences

Neodyne Biosciences is a commercial-stage medical device company focused on advanced scar management. Its flagship product, the embrace® Active Scar Defense system, is a unique, FDA-cleared device that combines proprietary Stress-Shield™ technology with medical-grade silicone to relieve tension on healing incisions, a key driver of scar formation. The product is supported by Level 1 clinical evidence from randomized controlled trials and is marketed directly to consumers and healthcare professionals for post-surgical and traumatic scar prevention. The company operates in the large and underserved dermatology and plastic surgery markets with a differentiated, clinically validated solution.

View full company profile